首页|Why are so few randomized trials useful, and what can we do about it?
Why are so few randomized trials useful, and what can we do about it?
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
There have been more than 300,000 randomized trials published since the landmark trial of streptomycin for tuberculosis was published in 1948 , This research design has become the sine qua non for licensing of pharmaceu-ticals, and is growing more influential in evaluation of other health care interventions such as surgery, continuing education, and the organization of care, as decision makers increasingly seek reliable evidence to inform their decisions.
NSTL
